Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11672)
All Articles published online
|
Publishing Process of This Article
|
Aug 18, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sachdeva M, Chawla YK, Arora SK. Immunology of hepatocellular carcinoma. World J Hepatol 2015; 7(17): 2080-2090 [PMID: 26301050 DOI: 10.4254/wjh.v7.i17.2080] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i17/2080.htm |
| Number | Citing Articles |
| 1 |
Fanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, Eiichi Ogawa, Masaru Enomoto, Dong Hyun Lee, Etsuko Iio, John Lubel, Wenjun Wang, Bin Wei, Tatsuya Ide, Carmen Monica Preda, Fabio Conti, Tatsuya Minami, Rob Bielen, Hitomi Sezaki, Michele Barone, Philippe Kolly, Po-sung Chu, Victor Virlogeux, Dennis Eurich, Linda Henry, Michelle B. Bass, Takanori Kanai, Shuangsuo Dang, Zongfang Li, Jean-François Dufour, Fabien Zoulim, Pietro Andreone, Ramsey C. Cheung, Yasuhito Tanaka, Norihiro Furusyo, Hidenori Toyoda, Akihiro Tamori, Mindie H. Nguyen. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Hepatology 2019; 71(3): 473 doi: 10.1016/j.jhep.2019.04.017
|
| 2 |
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. Cancers 2020; 12(6): 1491 doi: 10.3390/cancers12061491
|
| 3 |
Vinay Bharadwaj Tatipamula, Chandi Vishala Thonangi, Tikam Chand Dakal, Girija Sastry Vedula, Bhanupriya Dhabhai, Haritha Polimati, Annapurna Akula, Ha Thi Nguyen. Potential anti-hepatocellular carcinoma properties and mechanisms of action of clerodane diterpenes isolated from Polyalthia longifolia seeds. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13383-y
|
| 4 |
M. Murali, A. R. Kumar, B. Nair, K. Pavithran, A. R. Devan, G. K. Pradeep, L. R. Nath. Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance. Clinical and Translational Oncology 2022; 24(3): 407 doi: 10.1007/s12094-021-02707-5
|
| 5 |
Marta Ramirez-Pedraza, Mercedes Fernández. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02882
|
| 6 |
Joanne Marie O’Rourke, Vandana Mridhu Sagar, Tahir Shah, Shishir Shetty. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer. World Journal of Gastroenterology 2018; 24(39): 4436-4447 doi: 10.3748/wjg.v24.i39.4436
|
| 7 |
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Müller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Bömmel. Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens 2022; 12(1): 54 doi: 10.3390/pathogens12010054
|
| 8 |
Alex José de Melo Silva, Juliana Ellen de Melo Gama, Cleonilde Maria de Nascimento, Jessica Paula Lucena, Cicero Jadson da Costa, Camila Juliet Barbosa Fernandes, Danielle Maria Nascimento Moura, Helotonio Carvalho, Sheilla Andrade de Oliveira. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 85 doi: 10.1007/16833_2022_37
|
| 9 |
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
|
| 10 |
Chung-Feng Huang, Ming-Lung Yu. Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?. Clinical and Molecular Hepatology 2019; 25(2): 168 doi: 10.3350/cmh.2018.1014
|
| 11 |
Keya Bandyopadhyay, Idania Marrero, Vipin Kumar. NKT cell subsets as key participants in liver physiology and pathology. Cellular & Molecular Immunology 2016; 13(3): 337 doi: 10.1038/cmi.2015.115
|
| 12 |
Helena Degroote, Sander Lefere, Astrid Vandierendonck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models. Oncotarget 2021; 12(6): 562 doi: 10.18632/oncotarget.27906
|
| 13 |
Sichan He, Ian Lockart, Maryam Alavi, Mark Danta, Behzad Hajarizadeh, Gregory J. Dore. Systematic review with meta‐analysis: effectiveness of direct‐acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2020; 51(1): 34 doi: 10.1111/apt.15598
|
| 14 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1): 437 doi: 10.3390/ijms24010437
|
| 15 |
Guangwen Shu, Shanqing Jiang, Jun Mu, Huifan Yu, Huan Duan, Xukun Deng. Antitumor immunostimulatory activity of polysaccharides from Panax japonicus C. A. Mey: Roles of their effects on CD4 + T cells and tumor associated macrophages. International Journal of Biological Macromolecules 2018; 111: 430 doi: 10.1016/j.ijbiomac.2018.01.011
|
| 16 |
Edna Manda, Farai Chirove. A theoretical model of chronic hepatitis B virus with suboptimal adherence and drug resistance. Mathematical Methods in the Applied Sciences 2021; 44(2): 1298 doi: 10.1002/mma.6829
|
| 17 |
Han Ah Lee, Hyun Gil Goh, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Min-Goo Lee, Hyunggin An, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo. Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01833-2
|
| 18 |
Farshid Fathi, Reza F Saidi, Hamid Reza Banafshe, Mohsen Arbabi, Majid Lotfinia, Hossein Motedayyen. Changes in immune profile affect disease progression in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology 2022; 36: 039463202210784 doi: 10.1177/03946320221078476
|
| 19 |
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
|
| 20 |
Maryam Mehrabi, Fatemeh Amini, Shima Mehrabi. Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693076
|
| 21 |
Hyo Jung Cho, Geum Ok Baek, Chul Won Seo, Hye Ri Ahn, Suna Sung, Ju A Son, Soon Sun Kim, Sung Won Cho, Jeong Won Jang, Suk Woo Nam, Jae Youn Cheong, Jung Woo Eun. Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma. Cancer Medicine 2020; 9(15): 5459 doi: 10.1002/cam4.3230
|
| 22 |
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
|
| 23 |
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Yu-Ju Wei, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study. BMJ Open 2019; 9(5): e026703 doi: 10.1136/bmjopen-2018-026703
|
| 24 |
Chiara Taibi, Laura Vincenzi, Gianpiero D’Offizi. Hepatocellular Carcinoma. Updates in Surgery 2023; : 19 doi: 10.1007/978-3-031-09371-5_3
|
| 25 |
Weidong Shi, Lanyun Feng, Shu Dong, Zhouyu Ning, Yongqiang Hua, Luming Liu, Zhen Chen, Zhiqiang Meng. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma. Bioscience Reports 2020; 40(7) doi: 10.1042/BSR20194240
|
| 26 |
Pil Soo Sung, Eui-Cheol Shin. Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection. Journal of Clinical Medicine 2021; 10(2): 221 doi: 10.3390/jcm10020221
|
| 27 |
Seo-Young Koo, Eun-Ji Park, Chang-Woo Lee. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Experimental & Molecular Medicine 2020; 52(8): 1209 doi: 10.1038/s12276-020-0480-3
|
| 28 |
Grace Chappell, Grace O. Silva, Takeki Uehara, Igor P. Pogribny, Ivan Rusyn. Characterization of copy number alterations in a mouse model of fibrosis‐associated hepatocellular carcinoma reveals concordance with human disease. Cancer Medicine 2016; 5(3): 574 doi: 10.1002/cam4.606
|
| 29 |
Shou-Wu Lee, Li-Shu Chen, Sheng-Shun Yang, Yi-Hsiang Huang, Teng-Yu Lee. Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma. Viruses 2022; 14(11): 2316 doi: 10.3390/v14112316
|
| 30 |
Alexander D. Nardo, Nicole G. Grün, Maximilian Zeyda, Monika Dumanic, Georg Oberhuber, Elisa Rivelles, Thomas H. Helbich, Daniel F. Markgraf, Michael Roden, Thierry Claudel, Michael Trauner, Thomas M. Stulnig. Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma. Liver International 2020; 40(7): 1620 doi: 10.1111/liv.14464
|
| 31 |
Nighat Gull, Fareeha Arshad, Gowhar A. Naikoo, Israr Ul Hassan, Mona Zamani Pedram, Arif Ahmad, Alaa A. A. Aljabali, Vijay Mishra, Saurabh Satija, Nitin Charbe, Poonam Negi, Rohit Goyal, Ángel Serrano-Aroca, Mazhar S. Al Zoubi, Mohamed El-Tanani, Murtaza M. Tambuwala. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2023; 54(2): 368 doi: 10.1007/s12029-022-00809-z
|
| 32 |
Marcello Dallio, Moris Sangineto, Mario Romeo, Rosanna Villani, Antonino Davide Romano, Carmelina Loguercio, Gaetano Serviddio, Alessandro Federico. Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression. International Journal of Molecular Sciences 2021; 22(1): 436 doi: 10.3390/ijms22010436
|
| 33 |
Wei Sun, Baocai Xing, Lihai Guo, Zhilei Liu, Jinsong Mu, Longqin Sun, Handong Wei, Xiaohang Zhao, Xiaohong Qian, Ying Jiang, Fuchu He. Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep26499
|
| 34 |
Yanqiong Zhang, Chen Yan, Yuting Li, Xia Mao, Weiwei Tao, Yuping Tang, Ya Lin, Qiuyan Guo, Jingao Duan, Na Lin. Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis. Scientific Reports 2017; 7(1) doi: 10.1038/srep41925
|
| 35 |
Carol Stanciu, Cristina Maria Muzica, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Laura Huiban, Stefan Chiriac, Tudor Cuciureanu, Anca Trifan. An update on direct antiviral agents for the treatment of hepatitis C. Expert Opinion on Pharmacotherapy 2021; 22(13): 1729 doi: 10.1080/14656566.2021.1921737
|
| 36 |
June K. Dunnick, Arun R. Pandiri, Keith R. Shockley, Ronald Herbert, Deepak Mav, Dhiral Phadke, Ruchir R. Shah, B. Alex Merrick. Single nucleotide polymorphism patterns associated with a cancer resistant phenotype. Experimental and Molecular Pathology 2022; 128: 104812 doi: 10.1016/j.yexmp.2022.104812
|
| 37 |
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu. Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program. Clinical and Molecular Hepatology 2023; 30(1): 64 doi: 10.3350/cmh.2023.0287
|
| 38 |
Rebecca Allen, Daneng Li. Oncology in the Precision Medicine Era. 2020; : 259 doi: 10.1007/978-3-030-31471-2_16
|
| 39 |
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce Kah-Hoe Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 2018; 67(10): 1845 doi: 10.1136/gutjnl-2017-315201
|
| 40 |
WenYing Li, MingHao Chen, YuXin Gong, Feng Lin, Chen Sun. Effects of dexmedetomidine on oxidative stress, programmed cell death, liver function, and expression of peripheral immune cells in patients with primary liver cancer undergoing hepatectomy. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1159746
|
| 41 |
Sin-Ting Wang, Shi-Wei Huang, Kuang-Ting Liu, Teng-Yu Lee, Jeng-Jer Shieh, Chun-Ying Wu. Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway. Cell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0252-9
|
| 42 |
Namasivayam Subhapradha, Vairamani Shanmugam, Annaian Shanmugam. Chitosan nanoparticles from marine squid protect liver cells against N -diethylnitrosoamine-induced hepatocellular carcinoma. Carbohydrate Polymers 2017; 171: 18 doi: 10.1016/j.carbpol.2017.04.097
|
| 43 |
Leona von Hessen, Marie Roumet, Martin Helmut Maurer, Naomi Lange, Helen Reeves, Jean‐François Dufour, Pompilia Radu. High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma. Liver International 2021; 41(4): 828 doi: 10.1111/liv.14755
|
| 44 |
Pil Soo Sung, Moon Hyung Choi, Hyun Yang, Soon Kyu Lee, Ho Jong Chun, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Joon-Il Choi, Young Joon Lee, Si Hyun Bae. Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.600233
|
| 45 |
Edna Chilenje Manda, Faraimunashe Chirove. Acute hepatitis B virus infection model within the host incorporating immune cells and cytokine responses. Theory in Biosciences 2020; 139(2): 153 doi: 10.1007/s12064-019-00305-2
|
| 46 |
Yuan Yang, Ning Fu, Haiqing Wang, Jingcheng Hao. Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma. Medicine 2021; 100(48): e28135 doi: 10.1097/MD.0000000000028135
|
| 47 |
Elisa Feller Gonçalves da Silva, Kelly Goulart Lima, Gabriele Catyana Krause, Gabriela Viegas Haute, Leonardo Pedrazza, Anderson Velasque Catarina, Rodrigo Benedetti Gassen, Bruno de Souza Basso, Henrique Bregolin Dias, Carolina Luft, Maria Claudia Rosa Garcia, Bruna Pasqualotto Costa, Géssica Luana Antunes, Luiz Augusto Basso, Márcio Vinícius Fagundes Donadio, Pablo Machado, Jarbas Rodrigues de Oliveira. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence. Investigational New Drugs 2020; 38(6): 1653 doi: 10.1007/s10637-020-00941-2
|
| 48 |
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Journal of Histochemistry & Cytochemistry 2019; 67(5): 299 doi: 10.1369/0022155418824274
|
| 49 |
Arvind R. Murali, Subhash Chandra, Zoe Stewart, Bruce R. Blazar, Umar Farooq, M. Nedim Ince, Jeffrey Dunkelberg. Graft Versus Host Disease After Liver Transplantation in Adults. Transplantation 2016; 100(12): 2661 doi: 10.1097/TP.0000000000001406
|
| 50 |
Min Wu, Li Jiang. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2022; 67(1): 146 doi: 10.1007/s10620-021-06832-7
|
| 51 |
Astha Malik, Unmesha Thanekar, Surya Amarachintha, Reena Mourya, Shreya Nalluri, Alexander Bondoc, Pranavkumar Shivakumar. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.627701
|
| 52 |
Yue Zhao, Jiaxu Wang, Wai Nam Liu, Shin Yie Fong, Timothy Wai Ho Shuen, Min Liu, Sarah Harden, Sue Yee Tan, Jia Ying Cheng, Wilson Wei Sheng Tan, Jerry Kok Yen Chan, Cheng Ean Chee, Guan Huei Lee, Han Chong Toh, Seng Gee Lim, Yue Wan, Qingfeng Chen. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model. Hepatology 2021; 74(3): 1395 doi: 10.1002/hep.31812
|
| 53 |
Qinghui Wang, Huizhong Qian, Xiao Liu, Jian Jiang, Qingqin Hao. Plasma cytokine profile in occult HBV-infected blood donors. Future Virology 2023; 18(3): 155 doi: 10.2217/fvl-2022-0193
|
| 54 |
Ahmed H. Abed, smail A. Radwan, Ahmed Orabi, Khaled T. Abdelaziz. The combined effects of probiotic CLOSTAT® and Aviboost® supplement on growth performance, intestinal morphology, and immune response of broiler chickens. German Journal of Veterinary Research 2023; 3(3): 7 doi: 10.51585/gjvr.2023.3.0058
|
| 55 |
Chaoxing Li, Valentin Dinu. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma. Journal of Biomedical Informatics 2018; 81: 31 doi: 10.1016/j.jbi.2018.03.013
|
| 56 |
Markus Schoenberg, Jingcheng Hao, Julian Bucher, Rainer Miksch, Hubertus Anger, Barbara Mayer, Julia Mayerle, Jens Neumann, Markus Guba, Jens Werner, Alexandr Bazhin. Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients. Cancers 2018; 10(10): 389 doi: 10.3390/cancers10100389
|
| 57 |
Nicholas Koelsch, Masoud H. Manjili. From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment. International Journal of Molecular Sciences 2023; 24(15): 12086 doi: 10.3390/ijms241512086
|
| 58 |
Bin Sun, Dong Yang, Hongjiu Dai, Xiuyun Liu, Ru Jia, Xiaoyue Cui, Wenxuan Li, Changchun Cai, Jianming Xu, Xudong Zhao. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells. Cancer Immunology Research 2019; 7(11): 1813 doi: 10.1158/2326-6066.CIR-19-0026
|
| 59 |
Ahmed Salman, Mohamed Salman, Ahmed Moustafa, Hossam El-Din Shaaban, Ahmed El-Mikkawy, Safa Labib, Ahmed Youssef, Mahmoud Gouda Omar, Mohamed Matter, Hesham Elkassar. Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation. Journal of Hepatocellular Carcinoma 2021; : 313 doi: 10.2147/JHC.S300680
|
| 60 |
Guoxiu Yan, Xuefu Wang, Cheng Sun, Xiaodong Zheng, Haiming Wei, Zhigang Tian, Rui Sun. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02887-7
|
| 61 |
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala. Systems Challenges of Hepatic Carcinomas: A Review. Journal of Clinical and Experimental Hepatology 2019; 9(2): 233 doi: 10.1016/j.jceh.2018.05.002
|
| 62 |
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, Moein Ala. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome. Biomedicine & Pharmacotherapy 2023; 165: 115104 doi: 10.1016/j.biopha.2023.115104
|
| 63 |
Sunil K. Arora. Meet the Editorial Board Member. Current HIV Research 2022; 20(3): 199 doi: 10.2174/1570162X2003220913151824
|
| 64 |
Wei Xie, Lei Shi, Hu Quan, Hua Xiao, Jie Chen, Jia Liu, Jean de Dieu Habimana, Rongqi Huang, Jia Luo, Pan Chen, Zhiyuan Li. SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma. Cellular Oncology 2023; 46(5): 1285 doi: 10.1007/s13402-023-00811-y
|
| 65 |
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers 2021; 13(21): 5583 doi: 10.3390/cancers13215583
|
| 66 |
Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj. Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(23): 16773 doi: 10.3390/ijms242316773
|
| 67 |
F. Ji, B. Wei, Y. H. Yeo, E. Ogawa, B. Zou, C. D. Stave, Z. Li, S. Dang, N. Furusyo, R. C. Cheung, M. H. Nguyen. Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia. Alimentary Pharmacology & Therapeutics 2018; 47(5): 550 doi: 10.1111/apt.14507
|
| 68 |
Yonghua Shen, Ling Nie, Yuling Yao, LiQing Yuan, Zhenqing Liu, Ying Lv. Seminal vesicle metastasis after liver transplantation for hepatocellular carcinoma. Medicine 2019; 98(3): e13770 doi: 10.1097/MD.0000000000013770
|
| 69 |
Varun Peri, Eunice Lee, Michael Fink, Graham Starkey, Mehrdad Nikfarjam, Osamu Yoshino, Ruelan Furtado, Marie Sinclair, Adam Testro, Avik Majumdar, Robert Jones, Vijayaragavan Muralidharan, Marcos Vinicius Perini. A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2023; 27(7): 1376 doi: 10.1007/s11605-023-05681-1
|
| 70 |
Nadir Naveed Siddiqui, Ahtesham ul Haq, Owais Ali Siddiqui, Rizma Khan. DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association. Tumor Biology 2016; 37(8): 10487 doi: 10.1007/s13277-016-4941-1
|
| 71 |
Tianyu Mao, Rui Yang, Yi Luo, Kang He. Crucial role of T cells in NAFLD-related disease: A review and prospect. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1051076
|
| 72 |
K. Okrah, S. Tarighat, B. Liu, H. Koeppen, M. C. Wagle, G. Cheng, C. Sun, A. Dey, M. T. Chang, T. Sumiyoshi, Z. Mounir, C. Cummings, G. Hampton, L. Amler, J. Fridlyand, P. S. Hegde, S. J. Turley, M. R. Lackner, S. M. Huang. Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0068-8
|
| 73 |
Hongwu Tan, Shuyun Wang, Ludong Zhao. A tumour‐promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways. Clinical and Experimental Pharmacology and Physiology 2017; 44(2): 213 doi: 10.1111/1440-1681.12689
|
| 74 |
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann. Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 2023; 107(7): 1524 doi: 10.1097/TP.0000000000004487
|
| 75 |
Wenyong Huang, Wenjing He, Xiaomin Shi, Xiaoshun He, Lang Dou, Yifang Gao. The Role of CD1d and MR1 Restricted T Cells in the Liver. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02424
|
| 76 |
|
| 77 |
Hongyu Wang, Guixiong Zhang, Wenzhe Fan, Yanqin Wu, Jiang Zhang, Miao Xue, Yue Zhao, Wang Yao, Jiaping Li. Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE. Cancer Management and Research 2022; : 451 doi: 10.2147/CMAR.S342527
|
| 78 |
Xin-Cheng Mao, Shuo Shi, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Xiao Zhang, Cheng-Long Han, Bao-Wen Tian, Dong-Xu Wang, Si-Yu Tan, Zhao-Ru Dong, Yu-Chuan Yan, Tao Li. A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients. Biomarker Research 2023; 11(1) doi: 10.1186/s40364-023-00527-z
|
| 79 |
Kai Dai, Ling Huang, Ya-bing Huang, Zu-bing Chen, Li-hua Yang, Ying-an Jiang. 1810011o10 Rik Inhibits the Antitumor Effect of Intratumoral CD8+ T Cells through Suppression of Notch2 Pathway in a Murine Hepatocellular Carcinoma Model. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00320
|
| 80 |
Francesca Bonomini, Elisa Borsani, Gaia Favero, Luigi Rodella, Rita Rezzani. Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases. Nutrients 2018; 10(9): 1135 doi: 10.3390/nu10091135
|
| 81 |
Nataliia Petriv, Lavinia Neubert, Myroslava Vatashchuk, Kai Timrott, Huizhen Suo, Inga Hochnadel, René Huber, Christina Petzold, Anastasiia Hrushchenko, Andriy S. Yatsenko, Halyna R. Shcherbata, Heiner Wedemeyer, Ralf Lichtinghagen, Halina Falfushynska, Volodymyr Lushchak, Michael P. Manns, Heike Bantel, Halyna Semchyshyn, Tetyana Yevsa. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. OncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1874159
|
| 82 |
Ting Duan, Wenjie Sun, Mohan Zhang, Juan Ge, Yansu He, Jun Zhang, Yifan Zheng, Wei Yang, Han-ming Shen, Jun Yang, Xinqiang Zhu, Peilin Yu. Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile. Scientific Reports 2017; 7(1) doi: 10.1038/srep43745
|
| 83 |
Charlotte Rennert, Catrin Tauber, Pia Fehrenbach, Kathrin Heim, Dominik Bettinger, Özlem Sogukpinar, Anita Schuch, Britta Franziska Zecher, Bertram Bengsch, Sven A. Lang, Peter Bronsert, Niklas K. Björkström, Stefan Fichtner-Feigl, Michael Schultheiss, Robert Thimme, Maike Hofmann. Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma. Cells 2021; 10(6): 1369 doi: 10.3390/cells10061369
|
| 84 |
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1955 doi: 10.2147/JHC.S291553
|
| 85 |
Lysann Tietze, Sonja M. Kessler. The Good, the Bad, the Question–H19 in Hepatocellular Carcinoma. Cancers 2020; 12(5): 1261 doi: 10.3390/cancers12051261
|
| 86 |
Annalisa Boscolo, Eugenia Menin, Beatrice Zelaschi, Laura Albertoni, Giacomo Zanus, Fabio Baratto. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis. Experimental and Clinical Transplantation 2020; 18(1): 123 doi: 10.6002/ect.2017.0231
|
| 87 |
Riccardo Carloni, Simone Sabbioni, Alessandro Rizzo, Angela Dalia Ricci, Andrea Palloni, Cataldo Petrarota, Antonio Cusmai, Simona Tavolari, Gennaro Gadaleta-Caldarola, Giovanni Brandi. Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1445 doi: 10.2147/JHC.S390963
|